Nisenbaum said that the number of participants who provided cerebrospinal fluid samples was very small and since the drugmaker looked at many different biomarkers, its really hard to know how robust these findings are. However, if the biomarker results hold true, neurologist Dr
The fact that those with a BMI of 27kg/m 2 or higher according to the SELECT trial [27] could not be considered may also have had an impact
Patients who have had mixed or unclear GLP-1 responses in the past, or who want biomarker context before starting treatment, may benefit from PlexusDx's genetic-pathway option
doi: 10.1093/ajcn/69.6.1135
Well review your health history, discuss your goals, and then walk you through various treatment options so that you can decide what weight loss medication works best for you
Some patients reach their weight-loss goals at 1.0 mg weekly, while others benefit from titrating to 2.4 mg